According to a recent LinkedIn post from Oshi Health, the company is drawing attention to gaps in U.S. gastroenterology access and positioning virtual GI care as a potential solution. The post cites data that two-thirds of U.S. counties lack practicing gastroenterologists, while 15% of covered lives seek GI care each year, often without a clear diagnosis.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post highlights a recent PHTI report on virtual GI solutions and suggests benefits leaders should scrutinize whether offerings are effective only in regions with abundant specialist supply or across all geographies where employees live. Oshi Health emphasizes clinician-led virtual GI models that can diagnose, prescribe, and manage treatments remotely, implying a broader scope than triage-only digital tools.
For investors, this focus underscores a large addressable market in underserved counties and employer-sponsored health plans looking to improve GI access and outcomes. If Oshi Health can demonstrate superior clinical effectiveness and cost savings in line with the report’s benchmarks, it may strengthen its competitive position in the digital health space and support pricing power with payers and self-insured employers.
The framing around clinician-led care also suggests a strategy aimed at capturing higher-acuity, reimbursable services rather than solely low-margin navigation or wellness functions. This could support higher revenue per member while differentiating Oshi Health from lighter-touch virtual care offerings, though it may require greater investment in clinical infrastructure and provider networks.

